At a glance
- Originator Sanwa Kagaku Kenkyusho
- Class Anti-ischaemics
- Mechanism of Action L-selectin inhibitors; P selectin inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Retinal disorders
Most Recent Events
- 23 Apr 2001 Preclinical development for Retinal disorders in Japan (Unknown route)